Department of Surgery, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Ann Surg Oncol. 2018 Sep;25(9):2573-2578. doi: 10.1245/s10434-018-6526-2. Epub 2018 May 21.
Reoperation after breast-conserving surgery (BCS) is common and has been partially associated with the lack of consensus on margin definition. We sought to investigate factors associated with reoperations and variation in reoperation rates across breast surgeons at our cancer center.
Retrospective analyses of patients with clinical stage I-II breast cancer who underwent BCS between January and December 2014 were conducted prior to the recommendation of 'no ink on tumor' margin. Patient demographics and tumor and surgical data were extracted from medical records. A multivariate regression model was used to identify factors associated with reoperation.
Overall, 490 patients with stage I (n = 408) and stage II (n = 89) breast cancer underwent BCS; seven patients had bilateral breast cancer and underwent bilateral BCS procedures. Median invasive tumor size was 1.1 cm, reoperation rate was 22.9% (n = 114) and varied among surgeons (range 15-40%), and, in 100 (88%) patients, the second procedure was re-excision, followed by unilateral mastectomy (n = 7, 6%) and bilateral mastectomy (n = 7, 6%). Intraoperative margin techniques (global cavity or targeted shaves) were utilized in 50.1% of cases, while no specific margin technique was utilized in 49.9% of cases. Median total specimen size was 65.8 cm (range 24.5-156.0). In the adjusted model, patients with multifocal disease were more likely to undergo reoperation [odds ratio (OR) 5.78, 95% confidence interval (CI) 2.17-15.42]. In addition, two surgeons were found to have significantly higher reoperation rates (OR 6.41, 95% CI 1.94-21.22; OR 3.41, 95% CI 1.07-10.85).
Examination of BCS demonstrated variability in reoperation rates and margin practices among our breast surgeons. Future trials should look at surgeon-specific factors that may predict for reoperations.
保乳手术后(BCS)的再次手术是常见的,部分原因是在切缘定义上缺乏共识。我们旨在研究与我院癌症中心的乳腺外科医生再次手术相关的因素以及再次手术率的变化。
在推荐“无肿瘤墨渍”切缘之前,对 2014 年 1 月至 12 月期间接受 BCS 的临床 I 期至 II 期乳腺癌患者进行回顾性分析。从病历中提取患者人口统计学资料、肿瘤和手术数据。使用多变量回归模型确定与再次手术相关的因素。
共有 490 例 I 期(n=408)和 II 期(n=89)乳腺癌患者接受了 BCS;7 例患者患有双侧乳腺癌并接受了双侧 BCS 手术。浸润性肿瘤的中位大小为 1.1cm,再次手术率为 22.9%(n=114),且在外科医生之间存在差异(范围 15-40%),其中 100 例(88%)患者的第二次手术为再次切除术,其次是单侧乳房切除术(n=7,6%)和双侧乳房切除术(n=7,6%)。术中切缘技术(整体腔隙或靶向刮除)在 50.1%的病例中得到应用,而在 49.9%的病例中未应用特定的切缘技术。中位标本总大小为 65.8cm(范围 24.5-156.0cm)。在调整后的模型中,多发病灶的患者更有可能接受再次手术[比值比(OR)5.78,95%置信区间(CI)2.17-15.42]。此外,有两名外科医生的再次手术率明显较高(OR 6.41,95%CI 1.94-21.22;OR 3.41,95%CI 1.07-10.85)。
对 BCS 的检查表明,我们的乳腺外科医生在再次手术率和切缘实践方面存在差异。未来的试验应该着眼于可能预测再次手术的外科医生特定因素。